When does Gaudium IVF And Women Health IPO subscription close?

Gaudium IVF And Women Health IPO subscription closes on 2026-02-24.

GAUDIUMIVFEQ / NSE, BSEListed

Gaudium IVF And Women Health

Founded in March 2015, Gaudium IVF and Women Health Limited specializes in In Vitro Fertilization (IVF) and women’s healthcare services across India, operating through a hub-and-spoke model with seven hubs and twenty-eight spokes. The company collaborates with Infertility Experts to promote awareness of Assisted Reproductive Technology (ART) and IVF treatments. Serving patients from countries like Canada, the UK, the USA, Kenya, South Africa, and Oman, Gaudium has centres in key cities such as Delhi, Mumbai, Ludhiana, Srinagar, Patna, and Bangalore. It offers advanced fertility treatments including IVF, ICSI, IUI, ovulation induction, and male infertility solutions, along with specialized care for PCOD/PCOS, endometriosis, and high-risk pregnancies.

drhp anchor

₹75 - ₹797.27x sub

Listed Price₹83.00

Listing Gain+5.06%

GAUDIUMIVFEQ / NSE, BSEListed

Gaudium IVF And Women Health IPO Subscription

Q: What is the live subscription status of Gaudium IVF And Women Health IPO?

Gaudium IVF And Women Health IPO has been subscribed 7.27x overall across Qualified Institutional Buyers (QIB), Non-Institutional Investors (NII), and Retail Individual Investors.

drhp Document anchor Document

Price Band₹75 - ₹79

Lot Size189 shares

Min Bid₹14,931

Subscription7.27x

Listed Market Snapshot

₹83.00Listed price from market data

+5.06%listing gain

Issue Amount

₹165 Cr

Listed Price

₹83.00

Current Price

₹97.58

Registrar

Bigshare Services Private Limited

Subscription Status

7.27xTotal Demand

Updated 20 Oct 2026, 01:30 AM

QIB1.62x

Fully Subscribed (Safe)Offered: 41,77,240 sh

Nib14.05x

Hot Bidding (High Profits)Offered: 31,32,930 sh

Hnis(10l +)12.71x

Hot Bidding (High Profits)Offered: 20,88,620 sh

Hnis (2-10l)16.73x

Hot Bidding (High Profits)Offered: 10,44,310 sh

Retail7.60x

Popular / Warm DemandOffered: 73,10,170 sh

Category	Offered (Shares)	Applied (Shares)	Times Subscribed
QIB	41,77,240	67,85,478	1.62x
Nib	31,32,930	4,40,22,069	14.05x
Hnis(10l +)	20,88,620	2,65,55,634	12.71x
Hnis (2-10l)	10,44,310	1,74,66,435	16.73x
Retail	73,10,170	5,55,42,942	7.6x

Category	Offered	Applied	Times
QIB	41,77,240	67,85,478	1.62x
Nib	31,32,930	4,40,22,069	14.05x
Hnis(10l +)	20,88,620	2,65,55,634	12.71x
Hnis (2-10l)	10,44,310	1,74,66,435	16.73x
Retail	73,10,170	5,55,42,942	7.6x

Segment Subscription Demand

Segment / Category	Demand (Shares)	Offered (Shares)	Times Sub.
QIB	53.61	33	1.62x
Retail	438.79	57.75	7.60x
Hnis 2+	137.98	8.25	16.72x
Hnis 10+	209.79	16.5	12.71x

Application-wise Breakup

Category	Reserved	Applied	Times Sub.
Retail	38,678	2,40,713	6.22x
Hnis(10l +)	789	1,984	2.51x
Hnis (2-10l)	395	6,296	15.94x

Bidding status cross-verified with live IPO subscription numbers ↗BSE & NSE Bidding Portal Feed

About Gaudium IVF And Women Health IPO Subscription Demand

Live subscription status and bidding analysis for Gaudium IVF And Women Health (GAUDIUMIVF) IPO. The issue is subscribed 7.27x overall across Qualified Institutional Buyers (QIB), Non-Institutional Investors (NII/HNI), and Retail Individual Investors (RII). Check real-time grey market demand on our GMP Tracker or review full issue details, lot size, and price band on the IPO Details Page.